Importantly, activation of RAR/RXR signaling triggered by retinoids often exerts tumor-suppressive effects in mice, and loss of normal RAR function has been implicated in the progression of a diverse range of human cancers, including breast, lung, and colorectal carcinomas [9,10]. This evidence concerns the gene RARA and neoplasm.